ARCHIVES

Anamorelin Increases Body Mass In Two Global Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

MD Anderson Survey Shows Faculty Dissatisfaction with Top Leaders

May 23, 2014

Program Announcement Completes NCI switch To Control Research

April 16, 1982

Margaret Kripke Comes Out of Retirement To Become Chief Scientific Officer at CPRIT

December 14, 2012

White House names five to NCAB, reappoints Niederhuber as chairman.

June 25, 2004

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

April 22, 1988

In Brief: Pitot Appointed To Cancer Panel, Replacing Jako; Fisher, Wattenberg, Curtiss Lead Cancer Groups

May 29, 1992